Mebendazole and Ivermectin are two popular antiparasitic drugs that have a large preclinical research base confirming their effectiveness in many types of cancer and leukemia. There are also several cases of successful treatment of cancer in patients.
In this video, we will talk about the general characteristics of these drugs, how they destroy tumor cells, what studies exist on cells and animals.
In the second video, we will talk about Dr. Makis's unofficial protocol, doses, clinical trials on cancer patients, and the side effects and contraindications of ivermectin and mebendazole.
Join this channel to get access to perks:
https://www.youtube.com/channel/UCp0ictr-gVDu5tDBNvUgylA/join
To support channel:
1. PayPal https://www.paypal.me/marjoriepingkian96
2. BuyMeCoffee https://www.buymeacoffee.com/dratabekov
⚠️ WARNING! All information available at this channel is intended for general guidance only and must never be considered an individual recommendation or a substitute for medical advice provided by a doctor. Always seek the advice of your physician or other qualified health care professional regarding your medical condition.
In this video, we will talk about the general characteristics of these drugs, how they destroy tumor cells, what studies exist on cells and animals.
In the second video, we will talk about Dr. Makis's unofficial protocol, doses, clinical trials on cancer patients, and the side effects and contraindications of ivermectin and mebendazole.
Join this channel to get access to perks:
https://www.youtube.com/channel/UCp0ictr-gVDu5tDBNvUgylA/join
To support channel:
1. PayPal https://www.paypal.me/marjoriepingkian96
2. BuyMeCoffee https://www.buymeacoffee.com/dratabekov
⚠️ WARNING! All information available at this channel is intended for general guidance only and must never be considered an individual recommendation or a substitute for medical advice provided by a doctor. Always seek the advice of your physician or other qualified health care professional regarding your medical condition.
- Category
- Oncology

Be the first to comment